VF
CVKD icon

Virtu Financial’s Cadrenal Therapeutics CVKD Stock Holding History

Virtu Financial’s Portfolio CVKD Stock Details CVKD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,649
Closed -$12K – 1461
2024
Q2 		$12K Sell
1,649
-510
-24% -$3.53K ﹤0.01% 1108
2024
Q1 		$20K Buy
+2,159
New +$27.4K ﹤0.01% 1161
2023
Q4 		– Sell
-1,698
Closed -$17K – 1639
2023
Q3 		$17K Buy
+1,698
New +$24.1K ﹤0.01% 1035

Other funds holding CVKD

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Virtu Financial's CVKD Position: Q3 2024 in Review

Virtu Financial sold out of Cadrenal Therapeutics (CVKD) in Q3 2024, closing a stake of 1,649 shares — an estimated $12K sold.

Virtu Financial first reported a position in CVKD in Q3 2023 and held it in 3 quarters. The position peaked at $20K in Q1 2024. 2 funds tracked by Wall St. Rank hold CVKD as of Q3 2024.

  • Virtu Financial reported no remaining Cadrenal Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Virtu Financial sold 1,649 Cadrenal Therapeutics shares in Q3 2024, an estimated $12K.
  • Virtu Financial first reported a position in Cadrenal Therapeutics in Q3 2023 and held it in 3 quarters.
  • Virtu Financial's Cadrenal Therapeutics position peaked at $20K in Q1 2024.
  • 2 funds tracked by Wall St. Rank held Cadrenal Therapeutics as of Q3 2024.

Based on Virtu Financial's 13F filing for Q3 2024, filed 20 Nov 2024.